Menstruation Clinical Trials

A listing of Menstruation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 6779 clinical trials
Featured trial
Evaluating the Psychometric Properties of Three Clinical Trial Outcome Measures for Rett Syndrome

> The study consists of two components: a virtual research visit with our research team via Zoom and two, in-home collection periods using wearable technology. The virtual research visit will last

Online studies
  • 170 views
  • 30 Jun, 2022
  • 1 location
  • Online study
Featured trial
Real-World Compensatory Strategy Use

Older adults often spontaneously utilize compensatory strategies, or behaviors intended to make up for or work around a perceived deficit, to support successful completion of daily activities. In this study, we aim to enhance understanding of everyday functioning and compensatory strategy use in aging adults. Data collected will be used …

Online studies
Accepts healthy volunteers
  • 44 views
  • 24 Jan, 2023
  • 1 location
  • Online study
Featured trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study of the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis

The purpose of this study is to evaluate the efficacy and safety of INCB054707 in participants with prurigo nodularis over a 16-week double-blind placebo-controlled treatment period, followed by

  • 16 views
  • 28 Oct, 2022
  • 32 locations
Featured trial
Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI)  

Primary Objective: To evaluate the ability of dupilumab to reduce the need for rescue therapy with systemic corticosteroids (SCS) or surgery of AFRS in patients with AFRS who previously have had sino-nasal surgery Secondary Objectives: To evaluate the efficacy of treatment with dupilumab to reduce sinus opacification in a population …

  • 89 views
  • 27 Jan, 2023
  • 41 locations
Featured trial
Study of the Efficacy and Safety of Parsaclisib in Participants With Primary Warm Autoimmune Hemolytic Anemia (PATHWAY) (PATHWAY)

The purpose of this study is to evaluate the efficacy and safety of parsaclisib compared with placebo in participants with Primary Warm Autoimmune Hemolytic Anemia (wAIHA),

  • 11 views
  • 11 Nov, 2022
  • 39 locations
Featured trial
A Trial Evaluating Different Dosing Durations of TEPEZZA® Treatment in Patients with Thyroid Eye Disease (TED)

The overall objective is to investigate the safety, tolerability and need for re-treatment of 3 different TEPEZZA® treatment durations (4, 8, or 16 infusions) in patients with TED.

  • 29 views
  • 13 Oct, 2022
  • 14 locations
Featured trial
Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus (CLEan)

Primary Objective: Assess the efficacy of SAR443122 in cutaneous lupus erythematosus (CLE) Secondary Objectives: Assess the effect of SAR443122 on the physician's global assessment of disease activity (PhysGA - disease activity) Assess the effect of SAR443122 on CLE induced itch and overall pain Assess the effect of SAR443122 on the …

  • 25 views
  • 25 Jan, 2023
  • 5 locations
Featured trial
Assessment of Safety, Tolerability, and Efficacy Measured by Amyloid Reduction of LY3372993 in Early Symptomatic Alzheimer's Disease

The reason for this study is to collect safety and efficacy information regarding the study drug remternetug in participants with early Alzheimer's disease (AD).

amyloid
mini-mental state examination
  • 12 views
  • 15 Dec, 2022
  • 75 locations
Featured trial
A trial evaluating TEPEZZA® in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

The overall objective is to investigate the safety, tolerability and effect on insulin-like growth factor-1 (IGF-1), inflammatory and fibrotic biomarkers of TEPEZZA® administered once every 3 weeks (q3W) for 24 weeks in the treatment of participants with diffuse cutaneous systemic sclerosis (dcSSc).

  • 6 views
  • 11 Aug, 2022
  • 5 locations
Featured trial
A Study of TAK-341 in Treatment of Multiple System Atrophy

The main aim is to see how TAK-341 works after 52 weeks in participants with multiple system atrophy as measured by the Unified Multiple System Atrophy Rating Scale Part I (UMSARS). The study will enroll approximately 138 patients. Participants will receive a total of 13 intravenous infusions every 4 weeks …

  • 9 views
  • 14 Dec, 2022
  • 1 location